Related Experiment Videos

Why do schizophrenic patients refuse to take their drugs?

Archives of General Psychiatry

|July 1, 1974

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.

Journal of psychiatry & neuroscience : JPN·1994

Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection. Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol.

Journal of chromatography. B, Biomedical applications·1994

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients.

The American journal of psychiatry·1994

Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.

Archives of general psychiatry·1994

Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.

Therapeutic drug monitoring·1994

Schizophrenia.

The Psychiatric clinics of North America·1993

See all related articles